| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses | 20,250 | |||
| Cash and equivalents | 172,430 | |||
| Total current assets | 192,680 | |||
| Right of use assets | 566,353 | |||
| Furniture and computer equipment, net of accumulated depreciation of 4,585 and 3,326 as of june 30, 2025 and march 31, 2025 | 4,340 | |||
| Total assets | 763,373 | |||
| Current portion of lease liabilities | 167,673 | |||
| Current portion of notes payable and accrued interest | 2,843,132 | |||
| Accrued compensation | 862,869 | |||
| Other accrued liabilities | 25,453 | |||
| Accounts payable | 171,268 | |||
| Related party advances | 0 | |||
| Current portion of notes payable to shareholder and accrued interest | 486,112 | |||
| Current portion of notes payable to related parties and accrued interest | 295,664 | |||
| Total current liabilities | 4,852,171 | |||
| Lease liabilities, net of current portion | 458,858 | |||
| Total liabilities | 5,311,029 | |||
| Accumulated deficit | -8,806,475 | |||
| Common stock 0.001par value675,000,000shares authorized281,175,910and281,070,910issuedand outstanding at june 30, 2025 and march 31, 2025 | 281,176 | |||
| Additional paid-in capital | 3,977,643 | |||
| Total stockholders deficit | -4,547,656 | |||
| Total liabilities and stockholders deficit | 763,373 | |||
REGENEREX PHARMA, INC. (RGPX)
REGENEREX PHARMA, INC. (RGPX)